HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatyana Korontsvit Selected Research

Actinium-225

8/2020A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatyana Korontsvit Research Topics

Disease

22Neoplasms (Cancer)
12/2023 - 02/2004
7Leukemia
06/2017 - 08/2007
6Wilms Tumor (Wilm's Tumor)
12/2023 - 08/2007
3Bites and Stings (Sting)
11/2023 - 10/2015
3Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 05/2021
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 07/2010
2Ovarian Epithelial Carcinoma
11/2023 - 05/2023
2Melanoma (Melanoma, Malignant)
08/2020 - 06/2017
2Mesothelioma
10/2010 - 08/2007
2Malignant Mesothelioma
10/2010 - 08/2007
2Hypersensitivity (Allergy)
07/2010 - 02/2004
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2005 - 02/2004
1Hematologic Neoplasms (Hematological Malignancy)
12/2023
1Ascites
05/2021
1Testicular Neoplasms (Testicular Cancer)
06/2017
1Thoracic Neoplasms
10/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010
1Pathologic Complete Response
07/2010
1Lymphoma (Lymphomas)
12/2005
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2005
1Philadelphia Chromosome
02/2004

Drug/Important Bio-Agent (IBA)

14Peptides (Polypeptides)IBA
05/2021 - 02/2004
12AntigensIBA
12/2023 - 10/2005
6EpitopesIBA
11/2023 - 08/2007
5Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2005
5Oncogene Proteins (Oncogene Protein)IBA
01/2017 - 08/2007
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2023 - 10/2015
4WT1 ProteinsIBA
12/2023 - 08/2007
4HLA-A Antigens (HLA-A)IBA
01/2022 - 08/2014
4Transcription Factors (Transcription Factor)IBA
03/2013 - 08/2007
4VaccinesIBA
07/2011 - 02/2004
4Protein Subunit VaccinesIBA
07/2010 - 02/2004
3Chimeric Antigen ReceptorsIBA
12/2023 - 05/2023
3Neoplasm Antigens (Tumor Antigens)IBA
11/2023 - 01/2017
3Interferon-gamma (Interferon, gamma)IBA
10/2010 - 02/2004
2RMFPNAPYLIBA
11/2023 - 05/2023
2HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2023 - 05/2023
2HLA Antigens (Human Leukocyte Antigens)IBA
05/2021 - 12/2019
2LigandsIBA
05/2021 - 12/2019
2Histocompatibility Antigens Class IIBA
12/2019 - 01/2008
2AntibodiesIBA
06/2017 - 08/2014
2Monoclonal AntibodiesIBA
10/2015 - 08/2014
2EnzymesIBA
08/2007 - 02/2004
1PhosphopeptidesIBA
01/2022
1RNA (Ribonucleic Acid)IBA
05/2021
1Actinium-225IBA
08/2020
1Antineoplastic Agents (Antineoplastics)IBA
08/2020
1Melanocyte-Stimulating Hormones (MSH)IBA
08/2020
1Radioisotopes (Radionuclides)IBA
08/2020
1Silicon Dioxide (Silica)FDA LinkGeneric
08/2020
1Type 1 Melanocortin ReceptorIBA
08/2020
1Phosphotransferases (Kinase)IBA
12/2019
1Immunoglobulin G (IgG)IBA
07/2011
1Carbon Nanotubes (Carbon Nanotube)IBA
07/2011
1CytokinesIBA
10/2010
1HLA-DR Antigens (HLA-DR)IBA
08/2009
1Cyclin D1IBA
08/2009
1HLA-DRB1 Chains (HLA DRB1)IBA
08/2007
1Interleukin-18 (Interleukin 18)IBA
12/2005
1InterferonsIBA
02/2004
1Interferon-alpha (Interferon Alfa)IBA
02/2004
1Imatinib Mesylate (Gleevec)FDA Link
02/2004

Therapy/Procedure

5Immunotherapy
05/2021 - 08/2007
3Therapeutics
12/2023 - 07/2010
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2015
1Transplantation
02/2004
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2004